A DPP-4 inhibitor that lowers blood sugar without adding weight, taken as 50 mg once or twice daily.
Most people tolerate it well. But liver tests are not optional, and one drug pairing changes everything.
A patient-friendly guide by RealMedVision.
Medically reviewed: July 2026 | Last updated: July 2026 | 8 to 10 minute read
Quick answer
Vildagliptin is an oral tablet for type 2 diabetes. It helps the body release more insulin after meals and make less sugar between meals. The usual dose is 50 mg twice daily, or 50 mg each morning when taken with a sulfonylurea.
Key takeaways
- Works only when blood sugar rises, so lows are rare on its own.
- Maximum 100 mg a day, split into two doses.
- No weight gain, unlike sulfonylureas and insulin.
- Liver tests needed before starting and through year one.
- Sold across India and Europe, never approved in the United States.
If a doctor has just added this tablet to your prescription, the worry is usually the same. What will it do to me, and what should I watch for?
Vildagliptin tablet uses sit in type 2 diabetes, alone or beside metformin, once diet, exercise and a first medicine stop holding readings steady. Many people get it as a single combination tablet. Rising cases in younger Indian adults have made this group far more common than a decade ago.
What Is Vildagliptin and How Does It Work?
This medicine belongs to a family called DPP-4 inhibitors, often shortened to gliptins.
After a meal, the gut releases hormones called incretins. They tell the pancreas to send out insulin and the liver to slow its sugar release. An enzyme called DPP-4 breaks them down within minutes.
The tablet blocks that enzyme. Incretin levels stay higher for longer, so the pancreas answers food promptly.
Timing is the clever part. The effect switches on when blood sugar climbs and eases when it falls.
Vildagliptin Tablet Uses
Vildagliptin tablet uses centre on keeping blood sugar inside a safe range in adults with type 2 diabetes. It works alongside diet and exercise, never in place of them.
Doctors reach for it in a few familiar situations. It can be used alone when metformin upsets the stomach. More often it joins metformin once HbA1c stays above target. It can also be added to a sulfonylurea such as glimepiride or given with insulin to flatten after-meal spikes.
Vildagliptin 50 mg uses stay the same across all of these. Only the frequency and the partner medicine change.
What it will not do matters too. This is not a treatment for type 1 diabetes, not for diabetic ketoacidosis, and not a rescue tablet for a very high reading. Those need urgent care, and early warning signs should never be handled at home.
Vildagliptin Dose: 50 mg and 100 mg
The vildagliptin dose per day depends on what else is in the prescription.
| Situation | Dose | Timing |
|---|---|---|
| Vildagliptin alone | 50 mg twice daily | Morning and evening |
| With metformin | 50 mg twice daily | Morning and evening |
| With a sulfonylurea | 50 mg once daily | Morning only |
| Maximum daily dose | 100 mg | Split into two doses |
Vildagliptin 100 mg is the ceiling for one day, reached with two vildagliptin 50 mg tablets, one morning and one evening. Going higher adds risk without benefit.
The once-daily morning dose with a sulfonylurea exists for one reason. Sulfonylureas push out insulin whether or not sugar is high, so pairing them raises the chance of a low.
Patients ask about vildagliptin before or after food constantly. Either is fine. Food does not change how well the vildagliptin 50 mg tablet is absorbed, so pick times you will remember. Most settle on breakfast and dinner, then track results against a normal blood sugar range.
Miss a dose and the rule is simple. Take it when you remember. If the next dose is close, skip it. Never take two together.
If far more than prescribed has been swallowed, reach a hospital straight away, even when nothing feels wrong.
Reduced kidney function means a lower dose, guided by blood tests. Do not adjust it yourself.
Vildagliptin and Metformin Combination
Vildagliptin and metformin hydrochloride tablets uses are easy to explain. Two medicines lower blood sugar by different routes, and one tablet beats two.
Metformin works mainly on the liver, telling it to release less stored sugar. Vildagliptin works through the pancreas and gut hormones. Because the routes differ, the fall in HbA1c is larger than either manages alone.
Fixed-dose tablets in India pair 50 mg of vildagliptin with 500 mg, 850 mg or 1000 mg of metformin, taken twice daily with food. Eating alongside also softens the nausea metformin can cause.
One caution carries over from the metformin half. It brings a small risk of lactic acid build-up when kidney function is poor. Vildagliptin adds nothing to that risk, but kidney checks still apply.
Common Vildagliptin Brands in India
Vildagliptin tablets are sold under several brand names here. Galvus, Jalra, Zomelis and Vysov are widely stocked, and many companies sell plain generics.
Combination packs carry the same brand name with a suffix such as Met, signalling added metformin. Vildagliptin tablet uses do not change from one brand to the next.
Price swings a great deal by brand, strength and pharmacy. Generics cost noticeably less and hold the same active ingredient. Ask your pharmacist to lay out the options, the way patients compare semaglutide brands.
How Long Does Vildagliptin Take to Work?
Action begins with the first dose. The after-meal rise is trimmed within hours, and fasting readings usually settle over the first one to two weeks.
The fuller picture takes longer. HbA1c reflects average blood sugar across two to three months, so doctors recheck it around twelve weeks in. In trials, DPP-4 inhibitors lowered HbA1c by roughly 0.5 to 1.0 percentage points, with bigger falls in people who began higher. Compare your result against the HbA1c normal range.
Home readings help early on. Never judge a medicine on one number.
Vildagliptin Side Effects
Most people take this tablet without much trouble. The common vildagliptin side effects tend to be mild and often fade.
Dizziness is reported most. Headache, a blocked nose, mild tremor and nausea also appear, while constipation and joint pain turn up less often. Added to a sulfonylurea or insulin, low blood sugar becomes common, and that comes from the partner medicine. Swelling of the feet and ankles is more likely alongside pioglitazone.
Uncommon problems matter more, because they need action rather than patience.
Stop the tablet and contact a doctor the same day if you notice yellowing of the eyes or skin, dark urine, lasting tiredness with loss of appetite, or pain in the upper right abdomen. These can point to liver inflammation.
Seek emergency care for severe abdominal pain spreading to the back, with vomiting that will not stop. That is how pancreatitis usually announces itself.
Report blistering or peeling skin too, along with swelling of the lips, tongue or face with breathing difficulty. Both are rare, yet well recognised with this drug family.
Liver Function Monitoring: What Doctors Check
Monitoring is the one condition attached to vildagliptin tablet uses. The tablet can raise liver enzymes in a small number of people, usually with no symptoms, so tests sit inside the routine plan rather than waiting for something to feel wrong.
A liver function test measures enzymes called ALT and AST. Damaged cells leak them into the blood, so a rise is an early signal.
The usual schedule is a test before the first tablet, every three months through the first year, then periodically. Your doctor may test more often if other liver risks exist.
Treatment should not start when ALT or AST already reads more than three times above the upper normal limit. If levels climb past that mark later, the medicine is normally stopped. Most rises settle once it is withdrawn.
People with existing liver disease are steered towards a different option, and alcohol adds strain. Skipping these tests is the most common mistake made here, so put the dates in your calendar.
Low Blood Sugar Risk
Hypoglycaemia, or low blood sugar, is uncommon with vildagliptin alone. The tablet only nudges insulin release when glucose is already rising, so it does not keep pushing once levels drop.
Company changes that picture. Add a sulfonylurea such as glimepiride or insulin, and lows become a real possibility.
Learn the early signs: shakiness, sweating, a fast heartbeat, hunger, irritability and trouble concentrating. Treat at once with glucose tablets, a spoon of sugar or half a glass of juice, then recheck after fifteen minutes. Keep something sweet within reach while driving.
Clinical pearl. Vildagliptin usually does not cause weight gain and has a lower risk of hypoglycaemia when used alone compared with sulfonylureas. The risk rises when it is combined with insulin or a sulfonylurea.
Tell your doctor about every low. The usual fix is trimming the partner dose, not stopping vildagliptin.
Vildagliptin Drug Interactions
Vildagliptin has few drug interactions, one of its quieter advantages. It is not handled by the liver enzyme system most medicines compete over, so it neither blocks nor speeds up other drugs.
The interactions that count are about effect, not chemistry.
Insulin and sulfonylureas are the pair to watch. Both lower blood sugar alone, so the chance of a low rises, and doctors often cut those doses when starting. Alcohol belongs in the same box, since it blunts the liver’s ability to release stored sugar and can trigger a delayed low. Anyone on a weekly basal insulin should discuss this first.
ACE inhibitors taken for blood pressure, such as ramipril, slightly raise the risk of angioedema, a sudden deep swelling of the lips, tongue or face. The pairing is usually safe, but that swelling needs emergency care.
Steroid tablets such as prednisolone and thiazide water tablets push blood sugar upward. They do no harm here, they simply work against it.
Vildagliptin vs Sitagliptin vs Teneligliptin vs Glimepiride
Patients often ask about vildagliptin vs sitagliptin, and how gliptins stack up against older tablets.
| Medicine | Class | Hypoglycaemia risk | Weight effect | Dosing |
|---|---|---|---|---|
| Vildagliptin | DPP-4 inhibitor | Low when used alone | Neutral | 50 mg twice daily |
| Sitagliptin | DPP-4 inhibitor | Low when used alone | Neutral | 100 mg once daily |
| Teneligliptin | DPP-4 inhibitor | Low when used alone | Neutral | 20 mg once daily |
| Glimepiride | Sulfonylurea | High | Weight gain | Usually 1 mg to 4 mg once daily |
All three gliptins bring HbA1c down by a similar amount. Sitagliptin and teneligliptin win on convenience, while vildagliptin needs twice-daily dosing and liver testing.
Glimepiride is a different animal. It lowers sugar strongly and costs very little, yet it causes weight gain and carries a far higher risk of lows. That trade-off is why gliptins suit older people living alone.
Who Should Avoid Vildagliptin
Vildagliptin tablet uses have clear boundaries. This medicine is not for everyone.
It should not be used by anyone allergic to it, by people with type 1 diabetes, or during diabetic ketoacidosis. It is avoided in liver disease, where ALT or AST already sits three times above normal.
Pregnancy, breastfeeding and age under eighteen are reasons to choose something else, because safety data are lacking. In severe heart failure there is little clinical experience, so most doctors pick an alternative.
Reduced kidney function does not rule the tablet out. The dose is lowered instead.
Why Is Vildagliptin Not Approved in the US?
Vildagliptin is licensed in India, across Europe and in many other countries, but not in the United States. The manufacturer applied to the FDA, and the agency asked for further safety data, including on skin findings in animal studies and kidney signals in early trials. American approval was never pursued afterwards. Millions elsewhere have used it since, with a well mapped safety record.
Frequently asked questions
What are the benefits of vildagliptin?
It lowers blood sugar without causing weight gain, rarely causes lows when used alone, and suits people with reduced kidney function at an adjusted dose.
Is vildagliptin safe for kidneys?
Yes, it is not harmful to the kidneys. People with moderate or severe kidney impairment usually take a reduced dose, decided by their doctor after blood testing.
Should vildagliptin be taken before or after food?
Either works. Food does not affect absorption, so take it at the same times daily, commonly with breakfast and the evening meal.
Is vildagliptin the same as metformin?
No. They are different medicines from different groups and act on different organs. They are often prescribed together, sometimes combined into one tablet.
Which is better, vildagliptin or sitagliptin?
Neither is clearly better. Both lower HbA1c by a similar amount. Sitagliptin is once daily and needs no routine liver testing, which some doctors prefer.
Can vildagliptin cause low blood sugar?
On its own, rarely. Combined with insulin or a sulfonylurea such as glimepiride, lows are common, and the partner dose is usually reduced first.
Bottom line
Vildagliptin tablet uses come down to steady, weight-neutral blood sugar control in type 2 diabetes, most often beside metformin. The demands are twice-daily dosing and liver tests in year one. The real risk arrives with a sulfonylurea or insulin.
Disclaimer
This article is for general education only and does not replace advice from your own doctor. Do not start, stop or change any diabetes medicine on the basis of what you read here. Dosage, monitoring and safety depend on your personal health, test results and other prescriptions you take.
References
- EMA summary of product characteristics for Galvus vildagliptin, current version
- EMA European public assessment report for Galvus, authorised 2007
- EMA product information for Eucreas, vildagliptin with metformin
- ADA Standards of Care in Diabetes 2026, Diabetes Care volume 49
- NICE guideline NG28, type 2 diabetes in adults
- NHS guidance on type 2 diabetes
- WHO diabetes fact sheet
- Diabetes UK on diabetes and its treatment
- CDSCO, India drug regulator
- ICMR, Indian diabetes management guidance
Medically reviewed by
This guide was checked for medical accuracy by our review board before publishing.
Dr. Praveen Verma, MBBS, MD (Pathology), Pathologist and Clinical Laboratory Specialist.
Dr. Himanshu Morya, MBBS, Medical Educator.
Kalpna Singh Shekhawat, BSN, RN, NP
About the author
Iraphan Khan, BSN, RN, D.Pharm, is the founder of RealMedVision and a Public Health Researcher who creates evidence-based health content from trusted medical sources.
This article is for education and does not replace advice from your own doctor.